InvestorsHub Logo
Followers 212
Posts 32201
Boards Moderated 1
Alias Born 06/30/2009

Re: Jhawker post# 328667

Sunday, 10/18/2020 11:15:41 AM

Sunday, October 18, 2020 11:15:41 AM

Post# of 403159
"Again, is this because of an overly optimistic timeline or a slow and bureaucratic fda?"

That's an easy one so you tell me. Was this the fault of a slow FDA?

7/7/16
"In addition to evaluating efficacy in moderate to severe psoriasis, multiple secondary endpoints will be studied to provide insights regarding additional potential benefits of Prurisol compared to approved therapies. Our expectations are to initiate the trial late in the third quarter or early in the fourth quarter with top-line results in the second quarter of 2017.

Actual Study Start Date : November 2016


12/14/18
"On December 14, 2018, the Company completed its review of preliminary topline results for its Phase 2b clinical trial of oral Prurisol in moderate-to-severe chronic plaque psoriasis. Data was received the previous week."



I'll help:
No.


ps. Re: "I work for one of the largest medical device companies in the world and none of our projects is on time!"
Why does that not surprise me?

“I have had a wonderful time but this wasn't it.”
..........Groucho

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News